Xiaoling Liu Selected Research

tongxinluo

5/2019	Tongxinluo may stabilize atherosclerotic plaque via multiple mechanisms scanning by genechip.
1/2019	Carotid artery plaque intervention with Tongxinluo capsule (CAPITAL): A multicenter randomized double-blind parallel-group placebo-controlled study.
3/2016	Tongxinluo mitigates atherogenesis by regulating angiogenic factors and inhibiting vasa vasorum neovascularization in apolipoprotein E-deficient mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiaoling Liu Research Topics

Disease

32	Neoplasms (Cancer) 04/2022 - 11/2006
18	Infections 12/2021 - 05/2009
15	Inflammation (Inflammations) 04/2022 - 11/2013
13	Breast Neoplasms (Breast Cancer) 04/2022 - 07/2007
9	Leber Hereditary Optic Atrophy (Leber's Hereditary Optic Neuropathy) 01/2019 - 04/2014
7	Atherosclerotic Plaque (Atheroma) 01/2021 - 12/2014
7	Neoplasm Metastasis (Metastasis) 01/2021 - 11/2006
7	Autoimmune Diseases (Autoimmune Disease) 08/2018 - 01/2015
6	Allergic Rhinitis 03/2022 - 04/2005
6	Atherosclerosis 11/2021 - 11/2013
4	Body Weight (Weight, Body) 02/2021 - 04/2017
4	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 09/2010
4	Hemorrhage 01/2019 - 05/2015
3	Obesity 01/2022 - 12/2018
3	Insulin Resistance 12/2021 - 06/2008
3	Bacterial Infections (Bacterial Infection) 07/2021 - 01/2020
3	Tuberculosis (Tuberculoses) 02/2021 - 11/2020
3	Papillary Thyroid Cancer 01/2019 - 04/2015
3	Fibrosis (Cirrhosis) 01/2019 - 07/2013
3	Thrombosis (Thrombus) 01/2019 - 05/2015
3	Carcinogenesis 01/2018 - 11/2006
2	Wounds and Injuries (Trauma) 06/2022 - 01/2020
2	Rheumatoid Arthritis 05/2022 - 08/2018
2	Squamous Cell Carcinoma of Head and Neck 01/2022 - 03/2005
2	Polypoidal Choroidal Vasculopathy 01/2022 - 01/2021
2	Communicable Diseases (Infectious Diseases) 03/2021 - 04/2019
2	Heart Failure 02/2021 - 01/2021
2	Diabetes Complications 01/2021 - 12/2019
2	Acute Lung Injury 01/2021 - 01/2018
2	Proteinuria 01/2021 - 01/2018
2	Hyperoxia 01/2021 - 01/2017
2	Leukemia 05/2020 - 01/2019
2	Colonic Neoplasms (Colon Cancer) 07/2019 - 11/2007
2	Colorectal Neoplasms (Colorectal Cancer) 07/2019 - 01/2016
2	Macular Degeneration (Age-Related Maculopathy) 01/2019 - 09/2014
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2019 - 09/2014
2	Vision Disorders (Hemeralopia) 12/2017 - 08/2015
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2009 - 12/2006
2	Carcinoma (Carcinomatosis) 07/2007 - 11/2006

Drug/Important Bio-Agent (IBA)

16	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2009
8	Biomarkers (Surrogate Marker)IBA 01/2022 - 08/2016
8	Mitochondrial DNA (mtDNA)IBA 01/2019 - 04/2014
7	CytokinesIBA 01/2021 - 08/2015
6	Long Noncoding RNAIBA 03/2022 - 01/2019
6	LipidsIBA 01/2022 - 01/2017
5	IronIBA 04/2022 - 04/2018
5	KH902 fusion proteinIBA 01/2022 - 09/2014
5	Biological ProductsIBA 12/2021 - 02/2008
5	Estrogen ReceptorsIBA 01/2021 - 07/2007
5	Small Interfering RNA (siRNA)IBA 01/2021 - 08/2009
5	Apolipoproteins E (ApoE)IBA 01/2021 - 05/2015
4	HepcidinsIBA 07/2021 - 04/2018
4	Pharmaceutical PreparationsIBA 09/2020 - 04/2005
4	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 02/2008
4	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2015 - 09/2014
3	Retinaldehyde (Retinal)IBA 01/2021 - 01/2017
3	ginsenoside Rb1IBA 01/2021 - 01/2017
3	Messenger RNA (mRNA)IBA 02/2020 - 08/2009
3	tongxinluoIBA 05/2019 - 03/2016
3	CateninsIBA 01/2019 - 04/2015
3	B-Cell Activating FactorIBA 01/2017 - 01/2015
2	Oncogene Proteins (Oncogene Protein)IBA 04/2022 - 08/2009
2	C-Reactive ProteinIBA 04/2022 - 01/2019
2	VaccinesIBA 01/2022 - 04/2019
2	Phosphotransferases (Kinase)IBA 12/2021 - 01/2020
2	lipopolysaccharide-binding proteinIBA 11/2021 - 12/2018
2	RNA (Ribonucleic Acid)IBA 02/2021 - 01/2021
2	Adenosine (Adenocard)FDA LinkGeneric 01/2021 - 01/2017
2	LipopolysaccharidesIBA 01/2021 - 01/2016
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 01/2017
2	Phenobarbital (Luminal)FDA Link 01/2021 - 05/2015
2	CollagenIBA 01/2021 - 01/2019
2	Oxygen (Dioxygen)IBA 01/2021 - 01/2017
2	pigment epithelium-derived factorIBA 01/2021 - 05/2017
2	Cholecalciferol (Vitamin D3)FDA Link 12/2020 - 04/2020
2	Hemoglobins (Hemoglobin)IBA 10/2020 - 01/2015
2	Indicators and Reagents (Reagents)IBA 07/2019 - 10/2016
2	Capsules (Microcapsules)IBA 05/2019 - 01/2019
2	Hormones (Hormone)IBA 05/2019 - 01/2018
2	ApolipoproteinsIBA 01/2019 - 03/2016
2	MicroRNAs (MicroRNA)IBA 01/2019 - 12/2016
2	Progesterone Receptors (Progesterone Receptor)IBA 01/2018 - 04/2015
2	Estrogens (Estrogen)FDA Link 01/2018 - 04/2015
2	AntibodiesIBA 01/2018 - 01/2018
2	Triglycerides (Triacylglycerol)IBA 04/2017 - 06/2008
2	oxidized low density lipoproteinIBA 04/2017 - 11/2013
2	Immunoglobulin G (IgG)IBA 01/2015 - 11/2009
2	Leukotriene Antagonists (Leukotriene Receptor Antagonists)IBA 07/2014 - 04/2005
2	Cyclophilin AIBA 01/2013 - 12/2010
2	Cisplatin (Platino)FDA LinkGeneric 06/2008 - 07/2007
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 08/2022

Therapy/Procedure

10	Therapeutics 04/2022 - 01/2009
5	Drug Therapy (Chemotherapy) 01/2021 - 07/2007
4	Radiotherapy 01/2021 - 04/2015
3	Injections 01/2021 - 09/2014
3	Intravitreal Injections 01/2021 - 09/2017
3	Islets of Langerhans Transplantation 01/2009 - 12/2006
2	Photochemotherapy (Photodynamic Therapy) 01/2022 - 01/2021
2	Stents 11/2021 - 01/2020
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 05/2019 - 08/2018